Predictors of dementia in Parkinson’s disease: A population-based cohort study
Objective: To evaluate and describe characteristics of Parkinson's disease (PD) patients who develop dementia during follow-up in a longitudinal study. Background: Important non-motor features of…Response inhibition in Parkinson’s disease
Objective: To study the brain networks underlying Response Inhibition in Parkinson's disease (PD). Background: While some PD patients can have significant executive dysfunction, others remain…Transcranial sonography and cognitive dysfunction in Parkinson’s disease
Objective: To evaluate the role of transcranial sonography (TCS) in discriminating between Parkinson's disease (PD) patients with normal cognition (PDNC), mild cognitive impairment (PD-MCI) and…Monoaminergic biomarkers of cognitive decline in Parkinson’s disease and Lewy body dementia
Objective: The objective of this study was the identification of biochemical markers of cognitive impairment in Parkinson's disease (PD) and dementia with Lewy bodies (DLB)…Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size
Objective: To assess cognitive and neuropsychiatric effects of unilateral subthalamotomy in Parkinson´s disease (PD) and their correlation with lesion size. Background: Surgery for treatment of…Cognitive and psychiatric outcome 3 years after bilateral deep brain stimulation of the globus pallidus pars interna versus subthalamic nucleus for Parkinson’s disease
Objective: Comparing cognitive and psychiatric outcome 3 years after bilateral deep brain stimulation (DBS) of the globus pallidus pars interna (GPi) and subthalamic nucleus (STN)…Plasma ceramides and glucosylceramides predict cognitive decline among cognitively normal Parkinson’s disease patients
Objective: To determine whether plasma ceramides, glucosylceramides, and their ratios predict cognitive decline among cognitively normal Parkinson's disease (PD) patients. Background: There are no biomarkers…The role of neuroinflammation in the development of Parkinson’s disease dementia
Objective: To evaluate, at post-mortem, the pattern and characteristics of neuroinflammatory change in Parkinson's disease (PD) brain and to assess its relationship with aberrant alpha-synuclein,…Scores and dimensions to assess cognitive impairment in Parkinson’s disease
Objective: To provide inside into the nature of cognitive deterioration in Parkinson's disease dementia (PDD) and to define a score discriminating PDD patients from non-demented…The effect of dopamine on global versus specific inhibitory control in Parkinson’s disease
Objective: To evaluate the effect of dopaminergic medication on inhibitory control using a novel go/no-go task in Parkinson's disease (PD). Global cognition and motor examination…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.